From Reuters.

Weight-loss giant Novo Nordisk’s shares rose more than 5% to a high last hit in October, driven by ‘encouraging’ early US prescription data for its Wegovy pill, which the firm hopes will help it regain ground in the obesity drug race.

#News #Reuters #Newsfeed #novonordisk #wegovy #wegovyweightloss

Read the story here: https://reut.rs/4jSn55q

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en